No Data
Elevance Health Is Maintained at Buy by TD Cowen
Elevance Health Is Maintained at Buy by TD
Express News | TD Cowen Maintains Buy on Elevance Health, Lowers Price Target to $589
Baird Adjusts Price Target on Elevance Health to $625 From $649
Elevance Health (ELV) has an average rating of outperform and price targets ranging from $550 to $665, according to analysts by Capital IQ.Price: 503.00, Change: -1.72, Percent Change: -0.34
Elevance Health Second Quarter 2024 Earnings: EPS Beats Expectations
Express News | Elevance Health Inc : TD Cowen Cuts Target Price to $589 From $624
BofA Downgrades Elevance Health On Medicaid Pressure And Lowered Peer Valuations
Wednesday, Elevance Health Inc. (NYSE:ELV) reported second-quarter revenues of $43.2 billion, down 0.4% year-over-year, marginally above the consensus of $43.05 billion. The decrease was driven by